Skip to content
Nikhil KamathNikhil Kamath

Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma?

I got two of the biggest names in Indian pharma into one room, Rajeev Juneja of Mankind and GV Prasad of Dr. Reddy's, who'd somehow never actually met before this, and what came out was part masterclass and part origin story, from why being relentlessly contrarian beat following the herd, to how a college dropout from Meerut turned everything he hated about a medical store into a pharma giant, to why a chemical engineer who says he owes his career to his marriage spent decades chasing one original molecule, and somewhere in between we got into why India makes the world's generics instead of discovering its own drugs, what it really takes in time and money to bring a single drug to market, why GV thinks the AI-will-cure-everything story is overstated, where GLP-1s go next, and the one thing they'd tell a 25-year-old trying to build in pharma. #nikhilkamath Co-founder of Zerodha and Gruhas Host of 'WTF is' & 'People By WTF' Podcast Twitter: https://x.com/nikhilkamathcio/ Instagram: https://www.instagram.com/nikhilkamathcio/ LinkedIn: https://www.linkedin.com/in/nikhilkamathcio?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app Facebook: https://www.facebook.com/nikhilkamathcio/ Rajeev Juneja-Vice Chairman & Managing Director at Mankind Pharma Ltd LinkedIN- https://www.linkedin.com/in/rajeev-juneja-27882a24b/ G.V Prasad Reddy-MD & Co-Chairman at Dr. Reddy's Linkedin-https://www.linkedin.com/in/gvprasadster/ Watch 'WTF is' Podcast on Spotify https://tinyurl.com/4nsm4ezn Watch 'People by WTF' Podcast on Spotify https://tinyurl.com/yme92c59 Watch 'WTF Online' on Spotify https://tinyurl.com/4tjua4th 00:00 Introduction 04:27 Rajeev Juneja's path from medical-store apprentice to building Mankind 10:11 Mankind's contrarian OTC and bottom-up market strategy 16:23 G.V. Prasad on science and the Dr. Reddy's lineage 23:06 Segmenting the industry and how generic drugs are made 29:15 Why drug purity standards are shared but enforcement differs 36:40 Why India is the pharmacy of the world by volume, not revenue 41:00 How margins are split across the pharma value chain 45:17 Whether online pharmacy and consumer brands are real openings 53:15 Whether hospital roll-up valuations are justified 59:10 Tariffs, Jan Aushadhi and drug price controls 1:03:21 How China built a pharma-innovation ecosystem in a decade 1:10:02 Long-horizon governance and removing entrepreneurial fear 1:15:40 China's incentives, talent and leverage over the US 1:22:01 Why the Ayush and wellness market outgrows pharma 1:25:05 The evidence, quality and standardisation debate around Ayurveda 1:35:13 The sexual-wellness opportunity and the stigma problem 1:40:26 The fertility, IVF and egg-freezing opportunity 1:43:45 The API narrative debate and how a drug is synthesised 1:50:54 Biologics, monoclonal antibodies and vaccines explained 1:55:57 Stem cells and peptides, separating therapy from hype 2:00:06 The semaglutide story and how GLP-1 works 2:05:01 Mankind's ethical-selling philosophy on GLP-1 2:08:06 Why India leads in small molecules but lags in biologics 2:15:07 Where a young founder can enter the GLP-1 wave 2:23:38 The yin and yang of innovators and generics 2:29:05 Diagnostics, CDMO and the China-plus-one opportunity 2:37:18 Applying AI to pharma and the expired-medicine problem 2:43:01 Why founders should never copy a set formula 2:45:30 Succession, home diagnostics and the microfluidics frontier #WTFiswithnikhilkamath #PeopleByWTF #WTFOnline

Nikhil KamathhostRajeev JunejaguestG.V. Prasadguest
Jun 17, 20262h 51mWatch on YouTube ↗

Episode Details

EPISODE INFO

Released
June 17, 2026
Duration
2h 51m
Channel
Nikhil Kamath
Watch on YouTube
▶ Open ↗

EPISODE DESCRIPTION

I got two of the biggest names in Indian pharma into one room, Rajeev Juneja of Mankind and GV Prasad of Dr. Reddy's, who'd somehow never actually met before this, and what came out was part masterclass and part origin story, from why being relentlessly contrarian beat following the herd, to how a college dropout from Meerut turned everything he hated about a medical store into a pharma giant, to why a chemical engineer who says he owes his career to his marriage spent decades chasing one original molecule, and somewhere in between we got into why India makes the world's generics instead of discovering its own drugs, what it really takes in time and money to bring a single drug to market, why GV thinks the AI-will-cure-everything story is overstated, where GLP-1s go next, and the one thing they'd tell a 25-year-old trying to build in pharma. #nikhilkamath Co-founder of Zerodha and Gruhas Host of 'WTF is' & 'People By WTF' Podcast Twitter: https://x.com/nikhilkamathcio/ Instagram: https://www.instagram.com/nikhilkamathcio/ LinkedIn: https://www.linkedin.com/in/nikhilkamathcio?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app Facebook: https://www.facebook.com/nikhilkamathcio/ Rajeev Juneja-Vice Chairman & Managing Director at Mankind Pharma Ltd LinkedIN- https://www.linkedin.com/in/rajeev-juneja-27882a24b/ G.V Prasad Reddy-MD & Co-Chairman at Dr. Reddy's Linkedin-https://www.linkedin.com/in/gvprasadster/ Watch 'WTF is' Podcast on Spotify https://tinyurl.com/4nsm4ezn Watch 'People by WTF' Podcast on Spotify https://tinyurl.com/yme92c59 Watch 'WTF Online' on Spotify https://tinyurl.com/4tjua4th 00:00 Introduction 04:27 Rajeev Juneja's path from medical-store apprentice to building Mankind 10:11 Mankind's contrarian OTC and bottom-up market strategy 16:23 G.V. Prasad on science and the Dr. Reddy's lineage 23:06 Segmenting the industry and how generic drugs are made 29:15 Why drug purity standards are shared but enforcement differs 36:40 Why India is the pharmacy of the world by volume, not revenue 41:00 How margins are split across the pharma value chain 45:17 Whether online pharmacy and consumer brands are real openings 53:15 Whether hospital roll-up valuations are justified 59:10 Tariffs, Jan Aushadhi and drug price controls 1:03:21 How China built a pharma-innovation ecosystem in a decade 1:10:02 Long-horizon governance and removing entrepreneurial fear 1:15:40 China's incentives, talent and leverage over the US 1:22:01 Why the Ayush and wellness market outgrows pharma 1:25:05 The evidence, quality and standardisation debate around Ayurveda 1:35:13 The sexual-wellness opportunity and the stigma problem 1:40:26 The fertility, IVF and egg-freezing opportunity 1:43:45 The API narrative debate and how a drug is synthesised 1:50:54 Biologics, monoclonal antibodies and vaccines explained 1:55:57 Stem cells and peptides, separating therapy from hype 2:00:06 The semaglutide story and how GLP-1 works 2:05:01 Mankind's ethical-selling philosophy on GLP-1 2:08:06 Why India leads in small molecules but lags in biologics 2:15:07 Where a young founder can enter the GLP-1 wave 2:23:38 The yin and yang of innovators and generics 2:29:05 Diagnostics, CDMO and the China-plus-one opportunity 2:37:18 Applying AI to pharma and the expired-medicine problem 2:43:01 Why founders should never copy a set formula 2:45:30 Succession, home diagnostics and the microfluidics frontier #WTFiswithnikhilkamath #PeopleByWTF #WTFOnline

SPEAKERS

  • Nikhil Kamath

    host

    Entrepreneur and podcast host; co-founder of Zerodha.

  • Rajeev Juneja

    guest

    Pharma executive and co-founder of Mankind Pharma.

  • G.V. Prasad

    guest

    Pharma executive leading Dr. Reddy’s Laboratories; focuses on industry, R&D, and strategy.

EPISODE SUMMARY

In this episode of Nikhil Kamath, featuring Nikhil Kamath and Rajeev Juneja, Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? explores inside India’s pharma engine: generics, innovation gaps, and founder opportunities Rajeev Juneja explains how Mankind scaled via a contrarian, bottom-up go-to-market strategy—starting in small towns, prioritizing deep coverage, affordability, and brand-building through OTC visibility.

RELATED EPISODES

The $11B Bet That Voice Will Replace Everything | Mati Staniszewski x Nikhil Kamath | WTF Online

The $11B Bet That Voice Will Replace Everything | Mati Staniszewski x Nikhil Kamath | WTF Online

The AI Tsunami is Here & Society Isn't Ready | Dario Amodei x Nikhil Kamath | People by WTF

The AI Tsunami is Here & Society Isn't Ready | Dario Amodei x Nikhil Kamath | People by WTF

WTF Is Wealth? Ray Dalio Breaks It Down w/ Nikhil Kamath | WTF is Finance Ep 2

WTF Is Wealth? Ray Dalio Breaks It Down w/ Nikhil Kamath | WTF is Finance Ep 2

Tira, Bombay Shaving Co., Inde Wild | WTF is Fueling India’s Beauty & Skincare Revolution? | Ep. 25

Tira, Bombay Shaving Co., Inde Wild | WTF is Fueling India’s Beauty & Skincare Revolution? | Ep. 25

From Iran to Uber CEO | Nikhil Kamath x Dara Khosrowshahi | People by WTF | Ep. 14

From Iran to Uber CEO | Nikhil Kamath x Dara Khosrowshahi | People by WTF | Ep. 14

Nikhil Kamath x YouTube CEO, Neal Mohan | People by WTF Ep. 9

Nikhil Kamath x YouTube CEO, Neal Mohan | People by WTF Ep. 9

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.